Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced presentation of analyses of its previous Phase 3 program evaluating ampreloxetine, an ...

YUPELRI® (revefenacin) net sales of $58.3 million, recognized by Viatris, increased 6% versus Q1 20241 TRELEGY net sales of $854M, as reported by GSK, increased ...

Indian biopharma firm Biocon's profit more than doubled in the fourth quarter, led by strong demand for its generics and biosimilar drugs in its key U.S. and European markets.

AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody DrugsTOKYO, May 7, 2025 ...

The university revealed a refreshed brand identity shaped by input from its community and aligned with its strategic vision ...

MILAN (Reuters) -Italian fashion group OTB, which owns brands such as Diesel, Jil Sander and Maison Margiela, is assessing the extent of price increases in the United States if trade tariffs are ...

Following the acquisition of IFF Pharma Solutions, Roquette has created 2 complementary Business Groups: Health & Pharma ...

Although East Asians make up a significant share of entry-level roles in U.S. biopharma, few have risen to senior leadership ...

The Incucyte ® Live-Cell Analysis System is a fully automated platform for phase contrast and two-color fluorescence imaging, ...

RedHill acquired the exclusive worldwide rights to RHB-107, excluding China, Hong Kong, Taiwan and Macao, from Germany's ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") today announced that analyses of the initial Phase 3 program of ampreloxetine (Studies 169 and 170) will be presented at the ...

The dust is beginning to settle on Day 1 of the 2025 NFL Draft. A few prospects that had been commonly mocked in the first round are still available at the start of Day 2, including Colorado ...